UW-CTRI has 5 active studies. These include:
- UW-CTRI Outreach Program – JUUL Settlement. UW-CTRI has a grant to work with the Wisconsin Department of Health Services Tobacco Prevention and Control Program to help individuals ages 18-24 quit vaping. UW-CTRI will develop content for a brief, scalable, single-session intervention for 18–24-year-old e-cigarette users to promote cessation. Decisions about content and how the material would be presented will be co-designed with input from young adults, using focus groups of people who are ages 18-24 and currently or previously vape(d). The primary outcomes will be engagement with the intervention as well as changes in key attitudes, beliefs, and behavioral intention about quitting vaping. Karen Conner coordinates these efforts. January-December 2024, $193,000. Funded by the Wisconsin Tobacco Prevention and Control Program (TPCP). Jesse Kaye, PI.
- Predicting Patient Outcomes in Wisconsin and Nationwide Using the University of Wisconsin’s COVID-19 EHR Cohort Database. The major goal of this study is to utilize the COVID EHR Cohort at the University of Wisconsin (CEC-UW) database to improve the health and well-being of the people of Wisconsin. This will be accomplished by examining predictors of patient outcomes at the UW Health site specifically to those at other participating health systems. February 2022-January 2024, $300,000. Funded by Wisconsin Partnership Program. Michael Fiore and Tom Piasecki, PIs.
- R35 Outstanding Investigator Award. This seven-year grant will empower UW-CTRI to identify and disseminate effective, innovative ways to help cancer patients quit smoking. Specifically, UW-CTRI researchers, led by Dr. Michael Fiore, will further evaluate innovative approaches to helping cancer patients who smoke to quit. They’ll advance knowledge regarding interventions and health-system changes that will empower more patients living with cancer to break free from tobacco dependence. Research studies supported by this grant will identify effective interventions to help people with cancer quit smoking for good, as well as efficient and equitable ways to connect cancer patients with such treatments. UW-CTRI will work with diverse cancer-care programs across the nation to assist with implementing evidence-based smoking treatment for patients living with cancer. They’ll develop guides to disseminate the best strategies to cancer centers nationwide. In addition to Fiore, UW-CTRI Director of Research Dr. Danielle McCarthy and UW-CTRI Associate Director Dr. Tim Baker will lead the science. UW-CTRI Researcher Mark Zehner will manage the project. December 2022-December 2029, $6.5 million. Funded by the National Cancer Institute. Michael Fiore, PI.
- UW-CTRI Outreach Program – JUUL Settlement. UW-CTRI has a grant to work with the Wisconsin Department of Health Services Tobacco Prevention and Control Program to help individuals ages 18-24 quit vaping. UW-CTRI will develop content for a brief, scalable, single-session intervention for 18–24-year-old e-cigarette users to promote cessation. Decisions about content and how the material would be presented will be co-designed with input from young adults, using focus groups of people who are ages 18-24 and currently or previously vape(d). The primary outcomes will be engagement with the intervention as well as changes in key attitudes, beliefs, and behavioral intention about quitting vaping. Karen Conner coordinates these efforts. January-December 2024, $193,000. Funded by the Wisconsin Tobacco Prevention and Control Program (TPCP). Jesse Kaye, PI.
- Breaking Addiction to Tobacco for Health 2 (BREATHE 2). In a first, researchers at the University of Wisconsin are comparing the most effective treatments to help people quit smoking in real-world clinics, with a goal of tailoring and optimizing help to people who smoke. UW-CTRI is partnering with health systems to treat more than 4,000 clinic patients. They’re reaching out to patients listed as people who smoke in electronic health records to help those who are ready to quit and motivate those who aren’t. About 25 million people who smoke in America make a primary care visit each year, but only about five percent of people who smoke who try to quit use the cessation counseling and medication we know can help. In this study, the research team will reach out to them and offer these treatments. May 2019-May 2024, $12.5 million. Funded by NCI. Drs. Timothy Baker and Michael Fiore, PIs.